Axon Enterprise
This is the archived full research. Read the story
The company behind the TASER and most American police body cameras, which now sells police the cloud software their evidence, reports and dispatch run on.
The scores
Growth4/4 →
Revenue grew 33.5% in 2025 and 28% in Q3 2026, software 43% and recurring revenue 40%, on top of years above 30%.
Business quality4/4 →
One multi-year plan bundles evidence, cameras and TASERs; 126% retention holds although Motorola sells the same cameras and evidence software.
Financial position3/4 →
Net debt near $1.25B with nothing due before 2030, but free cash flow was only $75M in 2025 and is guided near $370M.
Execution record3/4 ↓
Years of 30% growth, but the 2026 outlook was cut on slipped federal drone deals and gross margin fell from 60.1% to 56.7%.
Per share capture2/4 ↑
Stock pay was 22.8% of 2025 revenue and diluted shares rose 35% since 2020; Skydio is partly paid in shares.
Potential3/4 ↑
Records, 911, drones and counter-drone multiply what each officer buys, but the newer lines are early and their market is management's sizing.
Risk profile3/4 →
Buyers are governments with appropriation clauses, antitrust scrutiny follows its share, and Motorola and Flock contest each new line.
Valuation1/4 ↑
About 143.5 times operating profit before depreciation, 204% of a three-stage value near $153 at an 8% return: priced for perfection, beyond the 20% margin.
Evidence quality3/4 →
Revenue, stock pay and the balance sheet are filed; recurring revenue, retention, bookings and the drone market are management's figures.
If it works 1.3× · if it fails you keep about 82%.
The Verdict
We rate Axon Unattractive. Its software grew 43% last quarter, and police customers spend more each year and rarely leave, so the business is solid. But stock pay takes about a sixth of revenue, so real profit is thin, margins fell and the outlook was cut on slipped deals. Even with stock pay fading and a steep growth path, the price is about twice our value and above our best case: the 2028 plan is already paid for. As a bet on drones and counter-drone it is defensive: little added if they work, little lost if not.
The long caseIf agencies that bought cameras from Axon add its drones, counter-drone and dispatch software, each officer's plan grows several times over.
How we weighed it
The price against our value
Against it
Price at 204% of our value
The price sits above our value and above the bull case, even on a steep path.
The business
In its favour
Solid
Customers rarely leave and spend more each year.
Growth against what the price assumes
In its favour
Software growth and customer retention both held through the quarter.
What could go wrong
Against it
Government budgets can cancel deals, rivals compete in newer tools and antitrust regulators are watching.
Against competitors
Cuts both ways
Priced close to its main rival on sales.
How its group is behaving
Cuts both ways
It sits in none of our ranked groups; public-safety budgets move it.
The latest news and report
Against it
The last report cut the outlook on slipped deals and margins fell.
The evidence under this - 8 claims
Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).
Retention and attrition are management's figures, and the FTC allegation was never tested (C21).
Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.
The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).
None of these lines is reported in the filings; the run rate is management's figure only.
The company
Police officers carry a TASER and wear a body camera; both come from Axon in most large American departments. The footage uploads to Axon Evidence, a cloud service where prosecutors and courts retrieve it. Around that Axon sells report writing with AI, records, dispatch and 911 software, and now drones and systems that stop drones.
Without it an agency would buy cameras, storage and software from several vendors, often Motorola, and stitch them together itself.
The evidence under this - 6 claims
Retention and attrition are management's figures, and the FTC allegation was never tested (C21).
How it makes money
Agencies sign multi-year plans that bundle devices with cloud software, paid each year. Software and services were nearly half of revenue last quarter and grow faster; TASERs, cameras and drones are the rest. Contracted future bookings of $15.8B, more than four years of revenue, keep the money coming.
The evidence under this - 4 claims
Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).
Where the money comes from, stream by stream
| Stream | Share of sales (2025) | How it earns it |
|---|---|---|
| Software and Services | 43% | Cloud subscriptions for evidence storage, records, real-time operations, AI tools and 911, plus set-up services, mostly billed over multi-year plans. |
| TASER | 33% | TASER devices, cartridges, extended warranties and training, mostly to police, also to consumers. |
| Personal Sensors | 14% | Body cameras, accessories and their warranties. |
| Platform Solutions | 10% | In-car and fixed cameras, interview rooms, drones and counter-drone equipment and virtual reality training hardware. |
Who runs it
Rick Smith founded the company as TASER International in 1993 and still runs it; he moved it into cameras and cloud software. Joshua Isner is president and Brittany Bagley runs operations and finance.
Smith owns 3.5%. His pay, and a plan for staff, vest only if the share price clears rising hurdles and revenue or profit goals are met. Insiders bought no shares in the past year and sold steadily, most of it under plans set in advance.
The evidence under this - 4 claims
Why it wins, and who could beat it
Why customers come back
An agency's years of evidence live in Axon's cloud, and its officers' TASERs, cameras and software arrive on one plan that renews together. Leaving means moving the evidence and retraining every officer.
The outside evidence: the Federal Trade Commission called Axon the dominant supplier to large city police in 2020, and existing customers spent 26% more in the past year.
The evidence under this - 4 claims
Retention and attrition are management's figures, and the FTC allegation was never tested (C21).
Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).
The FTC dismissed the case in October 2023 without a ruling on the merits (S11), so the allegation was never tested.
The threat
Motorola Solutions sells body and car cameras, evidence software and command centres to the same agencies, often beside its radios. Flock Safety, a private company, leads license plate readers and real-time centres and is moving into drones, while Axon says nearly 500 agencies have switched readers to it or are in talks.
The evidence under this - 3 claims
The Los Angeles police renewal still awaits city council approval months after the old contract expired, an analyst noted on the call.
The rivals: MSI, MSI, TYL, WRAP, BYRN, LMT, LHX, LDOS, VTSI, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| MSI | Motorola Solutions, with body cameras, evidence software and CommandCentralPriced against it: Yes | Software and Services: evidence storage, records, real-time operations and AI subscriptions | On sale | Yes |
| Motorola Solutions' body and in-car cameras | Body cameras, in-car video and fixed cameras | On sale | ||
| Private | Flock Safety's FlockOS and plate readers, and Mark43 records software, both privatePriced against it: Private | Software and Services: evidence storage, records, real-time operations and AI subscriptions | On sale | Private |
| TYL | Tyler Technologies' public safety records and dispatch softwarePriced against it: One segment only | Software and Services: evidence storage, records, real-time operations and AI subscriptions | On sale | One segment only |
| WRAP · BYRN | Wrap Technologies' BolaWrap and Byrna's pepper launchersPriced against it: Yes | TASER energy weapons, cartridges and training | On sale | Yes |
| Not listed | Smaller camera makers such as Getac, Hikvision and Reveal MediaPriced against it: Not listed | Body cameras, in-car video and fixed cameras | On sale | Not listed |
| Private | Flock Safety's Aerodome and BRINC, private drone-as-first-responder rivalsPriced against it: Private | Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone | On sale | Private |
| LMT · LHX · LDOS | Defence makers selling counter-drone systems: Lockheed Martin, L3Harris, Leidos and the private AndurilPriced against it: Not checked | Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone | On sale | Not checked |
| VTSI | VirTraPriced against it: One segment only | - | On sale | One segment only |
How big it could get
How big this could get
There are about 788,000 sworn officers in 17,541 American state and local agencies. In 2020, 62% of local departments used body cameras and 12% used drones, so the newer tools have room to spread.
Nobody publishes what an agency spends per officer on this kit, so the market cannot be put in dollars from outside the company.
The evidence under this - 4 claims
Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).
Who has signed
Contracts already signed and not yet delivered come to about $10.2B, and the company counts $15.8B of future bookings. Two deals last quarter were worth $258M and $115M. Government contracts can be cancelled if funding is not voted, and three federal counter-drone deals worth about $200M of bookings slipped.
The evidence under this - 4 claims
Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).
Bookings are unaudited and include contracts with cancellation clauses.
A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.
Where the growth is coming from, business by business
Where the growth is coming from
| Business | Share of revenue | Growth: last quarter | Last half-year | Last year | Share in 3 years at its latest-quarter rate |
|---|---|---|---|---|---|
| Software and Services: evidence storage, records, real-time operations and AI subscriptions | 48% | +43.2% | - | - | 59% |
| Body cameras, in-car video and fixed cameras | 26% | +42.4% | - | - | 31% |
| TASER energy weapons, cartridges and training | 26% | -2.1% | - | - | 10% |
| Whole company | 100% | +27.8% | - | - | 100% |
On the filed split through 2026-09-30, if each business keeps its latest quarter's growth, the company grows about 31% next year and 37% in year 3, against 33.6% over the last twelve months. Software and Services: evidence storage, records, real-time operations and AI subscriptions carries the case: it grows 43% against 20% for the rest, and would be 59% of revenue by then. A scenario, not a forecast: no business holds its rate.
How we read it: The score believes the software line: it is nearly half of revenue, grows twice as fast as devices and carries the recurring revenue, so the blend understates where growth is heading.
The results
The numbers
Sales grew 34% over the twelve months to Sep 2026, about the same pace as the 33% in the year to Dec 2025.
Operating margin is 2.0%, down from 10% in the year to Dec 2023.
Running costs take 57¢ of each sales dollar, down from 82¢ in the year to Dec 2021.
Each dollar put into the business earns 1.2% a year after tax, about where it was (4.6%) in the year to Dec 2022.
It turned 2.4% of sales into free cash, $80.9M over the last twelve months.
It owes $1.21B more than the cash it holds, about 5.4 years of the cash its operations bring in.
The share count rose 26% in 4.8 years, and pay in shares costs 19% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $866M | $1.19B | $1.56B | $2.08B | $2.78B | $3.42B |
| Sales growth | +27% | +37% | +31% | +33% | +33% | +34% |
| Profit | ||||||
| Gross margin | 63% | 61% | 61% | 60% | 60% | 59% |
| Operating margin | −19% | 7.8% | 10% | 2.8% | −2.2% | 2.0% |
| Net margin | −6.5% | 12% | 11% | 18% | 4.5% | 7.6% |
| What growth costs, per sales dollar | ||||||
| Research and development | 22% | 20% | 19% | 21% | 25% | 23% |
| Selling, general and admin | 59% | 34% | 32% | 36% | 37% | 34% |
| Pay in shares | 35% | 8.9% | 8.4% | 18% | 23% | 19% |
| Capital spending | 5.8% | 4.7% | 3.8% | 3.8% | 4.9% | 4.2% |
| Cash | ||||||
| Cash from operations | $124M | $235M | $189M | $408M | $211M | $225M |
| Free cash flow | $74.6M | $180M | $130M | $330M | $75.1M | $80.9M |
| Balance sheet | ||||||
| Cash and short-term investments | $371M | $935M | $1.24B | $788M | $1.71B | $1.66B |
| Debt | - | $674M | $677M | $680M | $1.81B | $2.87B |
| Net cash | - | $261M | $565M | $108M | −$104M | −$1.21B |
| Returns and shares | ||||||
| Return on capital | - | 4.6% | 7.4% | 2.2% | −1.5% | 1.2% |
| Shares (diluted) | 66.2M | 72.5M | 75.5M | 78.6M | 82.4M | 83.7M |
What growth costs
Growth has been getting more expensive. Research and selling costs have risen faster than revenue, mostly because of stock pay, so reported profit fell to a loss in 2025 before recovering slightly this year. Management expects stock pay to fall as a share of revenue.
The evidence under this - 3 claims
The last report (5 Nov)
Quarter ended September 2026, filed figures.
In the quarter to September 2026 revenue rose 28% to $908.6M. Software and services rose 43% and newer software lines reached about $500M a year at their current pace. Devices grew more slowly, and gross margin fell from 60.1% to 56.7% on counter-drone hardware, tariffs and the cost of running AI.
Three federal counter-drone deployments slipped past year end, so Axon cut its 2026 revenue outlook to about 30% growth. Management says it will now guide such deals only once confident they ship.
What it did to the thesisIt supported the software engine: growth and retention held. It weakened the profit side: margins fell and the outlook was cut on deals that slipped, so the plan's timing is less certain and our view holds.
The quarter in detail
Sales growth from the previous quarter, filed figures. The company has restated its own history, so a quarter either side of the restatement may describe a different business; n/c marks one that does not compare.
Earnings per share $1.72 against $1.89 expected; $0.68 as filed, the gap being what the company adds back.
The evidence under this - 6 claims
Management says the deals are delayed, not lost, and will be counted as upside if they ship by year end (C32).
A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.
None of these lines is reported in the filings; the run rate is management's figure only.
What management did with the money
Insiders in 2026Q3: 16 purchases and 128 sales, from their Form 4 filings.
The price, and where we disagree
In short. Priced for perfection. The price is about 204% of what we think the business is worth, at an 8% yearly return.
The shares halved in a year while revenue per share rose 25%, and fell 26% in two days after the third-quarter report, when the counter-drone deals slipped. After similar drops in 2025 and August 2026 the price recovered within weeks.
The next test is the fourth-quarter report, expected on 23 February 2027, with the 2027 outlook: how fast revenue grows and how much stock pay falls.
The evidence under this - 5 claims
Management says the deals are delayed, not lost, and will be counted as upside if they ship by year end (C32).
A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- A strong moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 15.9%, 14.2% | 31.8%, 28.5% | 39.8%, 35.6% |
| Normal operating margin | 10.9% | 13.7% | 15% |
| Return on new capital after year ten | 8% | 15% | 15% |
| Value a share | $45.09 | $153 | $216 |
- Price
- $313
- Priced on
- 6 Nov
- Price as a share of the base value
- 204%
- Yearly return the price offers on the base case
- 6.2%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $87.58
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Tax rate | Our method's rule | The normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 31 Dec 2025, filed 25 Feb 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026 and 31 Dec 2027, as it stood when the value was struck on 10 Nov 2026: the average of 13 to 15 analysts' revenue estimates, 31.8%, 28.5%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, the average of 14 analysts' estimates, 23.7%, less stock pay of 6% of sales and less the 3% the analysts add back on their adjusted basis: 14.7%, which the base case takes as 13.7%. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 16% and 14%, the margin settles a fifth lower at 10.9%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 32% and 28% over three years, the analysts' path (C52), then fades toward 4%, closing 30% of the gap each year; the margin moves to 13.7%, the analysts' year-three figure after stock pay and on the filed basis (3.0% less), with stock pay, today 18.8% of sales, at a mature 6%.
Bull caseGrowth runs a quarter above the analysts' path, 40% and 36%, the margin reaches 15.0%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $120 | $194 |
| The normal margin, 15% lower or higher | $125 | $182 |
| Capital per dollar of growth, a quarter more or less | $146 | $158 |
| Return on new capital after year ten, at the rate or one step up | $101 | $153 |
| The rate, a point higher or lower | $114 | $220 |
| Long-run growth a point lower | $129 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 11% | $69.63 | $90.24 | $116 | $146 | $184 |
| 12.3% | $81.21 | $105 | $134 | $170 | $213 |
| 13.7% | $92.79 | $120 | $153 | $194 | $243 |
| 15.1% | $104 | $135 | $172 | $218 | $273 |
| 16.4% | $116 | $150 | $191 | $241 | $302 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Management's profit measure leaves out stock pay. We count it as the cost it is.
- The whole company, debt included and cash taken off, is worth about $26.7B.
- This year's guided profit, less about $585M of stock pay, is about $340M: about 78 times.
- The 2028 targets, $6B of revenue at a 28% margin, less about $650M of stock pay, give about $1.03B.
- Today's value is about 26 times that, so the plan landing on time is what the price assumes.
Against its own history. Well below its own six-year normal on company value per dollar of cash profit, so the market has stopped paying the old premium for growth.
The evidence under this - 4 claims
Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.
Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).
The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).
Priced against its rivals
The competitors its own annual report names, each confirmed against the rival's filing. Measured on company value for each $1 of sales, cheapest first:
| Ticker | Company | company value for each $1 of sales |
|---|---|---|
| MSI | Motorola Solutions | 7.5× |
| AXON | Axon Enterprise | 7.6× |
| WRAP | Wrap Technologies | 11.3× |
The middle of the other 2 is 9.4. Axon Enterprise, Inc. is 2nd cheapest of 3.
Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.
Just above Motorola and below the much smaller Wrap, so on sales Axon is priced close to its main rival; the group is too small to say more.
The bet: what it pays if it works
This bet is on Axon's newer lines: AI tools, real-time centres, 911, drones and systems that stop drones. Local police were allowed to run counter-drone operations only from July 2026, and the federal deals have slipped.
Valued alone, TASERs, cameras and evidence software do not cover today's price, so part of the price already rests on the newer lines. If they treble, the shares gain only modestly; if they never earn, little is lost, which makes it a defensive and expensive bet.
| Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue in two to three years | US agencies equipped with drones needed | At the stated multiple |
|---|---|---|
| $1.50B (the big win) | about 4.5K at 30% kept | 1.3× |
| $2.50B | about 9.0K at 30% kept | 1.6× |
To pay 2× (a Fair bet) it would need about $3.80B of Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue (about 14.8K US agencies equipped with drones at 30% kept); to pay 5× (a Cheap bet), about $13.48B of Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue (about 58.4K US agencies equipped with drones at 30% kept), at the same multiple.
Each row is Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone alone, plus the rest of the company (TASERs, cameras and evidence software) counted at about $21.25B.
The steps it has to take
- Done Local police allowed to run counter-drone operations
- Slipped Slipped federal counter-drone deployments ship due 2027-06
- In progress Skydio investment closes due 2027-03
- Not started Newer-line run rate reported above one billion dollars due 2028-03
The detail behind the label
The evidence under this - 6 claims
None of these lines is reported in the filings; the run rate is management's figure only.
A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.
The market size is Axon's own estimate and is not built from units anywhere in the filing.
Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.
The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).
Where we disagree with the market
A 30% grower held back by timing, still mostly buy-rated, with targets far above the price.
The software engine is real, but stock pay and newer hardware keep profit per share well behind revenue.
Analysts value Axon on management's profit, which adds stock pay back. Counted as a cost, the plan needs stock pay to fall to about a ninth of revenue by 2028, and the price already assumes it.
The evidence against us: if the 2027 outlook shows stock pay falling fast while growth holds near 25%, today's price would look cheap.
What analysts say, and the evidence
The evidence under this - 6 claims
Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.
The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).
Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).
What could go wrong, and how we would know
The risks
- Government budgets. Agencies can cancel when funding is not voted, and federal counter-drone deals already slipped once.
- Rivals in newer tools. Motorola and Flock compete in every new line, from plate readers to real-time centres and drones.
- Antitrust. Regulators have called Axon dominant before; another challenge could limit acquisitions or bundling.
- Stock pay stays high. If stock pay does not fall as planned, each share keeps getting a smaller slice of the profit.
- Hardware squeezes margins. Drones, counter-drone and new cameras earn less than software and carry tariffs and memory costs.
The evidence under this - 8 claims
A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.
The FTC dismissed the case in October 2023 without a ruling on the merits (S11), so the allegation was never tested.
What we still do not know
- How much the newer lines, drones and counter-drone especially, earn on their own; Axon reports only one combined figure for them.
- How fast stock pay falls as a share of revenue after 2026.
- What the Skydio stake earns Axon, and whether it leads to full ownership.
The evidence under this - 4 claims
None of these lines is reported in the filings; the run rate is management's figure only.
The market size is Axon's own estimate and is not built from units anywhere in the filing.
Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).
What would change our view
- Unattractive→NeutralThe price falls back within 20% of fair value
It needs:
- ○The share price falls to about $184, back within 20% of what we think the business is worth.about ≈$189.76 today, 39% below the last close
- Unattractive→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $123, 80% of what we think the business is worth.about ≈$131.09 today, 58% below the last close
- Unattractive→AttractiveStock pay falls while growth holds
It needs all of:
- ○The 2027 outlook puts stock pay below 13% of revenue.checked at the next results, due by 23 Feb
- ○The 2027 outlook keeps revenue growth at 25% or more.checked at the next results, due by 23 Feb
We would also be wrong if
- A top-ten American city moves its body cameras and evidence to another vendor.
What is coming
- 23 February 2027 Q4 2026 results and 2027 outlook: Whether 2027 is guided near 25% growth, whether stock pay falls as a share of revenue, and whether the federal Dedrone deals shipped.
Every dated event ahead
- 23 February 2027 Q4 2026 results and 2027 outlook: Whether 2027 is guided near 25% growth, whether stock pay falls as a share of revenue, and whether the federal Dedrone deals shipped.
- 31 March 2027 Skydio investment closes: How many shares are issued and when drone sales start flowing through Axon.
- 30 June 2027 Axon Body 5 ships: Whether the new camera starts an upgrade cycle after the Q1 pause management expects.
Since we wrote this
- 11 NovThesis reviewUnattractive, high conviction: the view holds even in our best caseConviction re-graded on the new anchors: how robust the view is, not whether anything is still open.
- 9 NovThesis writtenNeutral, medium convictionThe police platform grows fast and customers stay, but after stock pay the halved price still pays for the 2028 plan.
- 9 NovThesis reviewUnattractive: priced at 185% of a value near $169Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
Sources 17
Sources - 17
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-25business, segments, sales by product line, competition, customers, suppliers, risk factors and the five-year statementsbacksC01C02C09C11C13C16C26C27C28C39C43C44C48
- S02primarycompany filing2026-02-242025 results, annual recurring revenue, bookings, the 2026 outlook and the 2028 targetsbacksC19C49
- S03primarycompany filing2026-11-05Q3 2026 results by product line and segment, margins, stock pay, cash and notes, recurring metrics, large bookings and the cut 2026 outlookbacksC03C04C06C07C08C09C10C11C12C20C33C34C35C36C39C46C47C50
- S04primarycompany filing2026-11-05the Skydio investment, the stake, the exclusive distribution rights and Skydio's bookings and customersbacksC14C15
- S05primarycompany filing2026-11-06remaining performance obligations, the notes and their conversion terms, the diluted share count and the shares outstandingbacksC05C12C13C16C38C49
- S06primarytranscript2026-11-05Third quarter 2026 earnings call transcript (FMP), held 2026-11-05data/cache/transcripts/AXON-2026Q3.jsonmanagement on the federal Dedrone delays, Skydio, inventory, memory costs, TASER, Body 5, Axon 911 and the license plate reader dispute
Together, they represent about $130 million of revenue and $200 million of bookings that we expected in the second half of this year.
backsC06C14C32C33C34C35C41 - S07primarycompany filing2026-04-16share ownership, the CEO Performance Award and Employee XSP hurdles, and what vested in 2025backsC29C30C48
- S08primarygovernment data2023-11-01Bureau of Justice Statistics, Local Police Departments, Procedures, Policies, and Technology, 2020 (November 2023, NCJ 307405) Bureau of Justice Statisticsthe share of local police departments and officers using body-worn cameras in 2016 and 2020, conducted energy device authorisation and drone cameras
In 2020, 62% of local police departments used body-worn cameras, a 43% increase from 2016
backsC22C23 - S09primarygovernment data2022-10-01Bureau of Justice Statistics, Census of State and Local Law Enforcement Agencies, 2018 (October 2022, NCJ 302187) Bureau of Justice Statisticsthe number of state and local law enforcement agencies and sworn officers
agencies employed 1,214,000 persons on a full-time basis, including 788,000 (65%) sworn and 427,000 (35%) civilian personnel.
backsC24 - S10primaryregulator2020-04-23Federal Trade Commission, Axon Enterprise and Safariland: Analysis of Consent Order to Aid Public Comment (Federal Register, 23 April 2020) Federal Trade Commissionthe regulator's description of Axon's position in body cameras and evidence systems for large police departments, and of its prices after the VieVu purchase
The merger eliminated direct and substantial price and innovation competition between dominant supplier Axon and its closest competitor, VieVu, to serve large metropolitan police departments.
backsC21 - S11primarycompany release2023-10-09Axon news release: Federal Trade Commission dismisses antitrust complaint against Axon (PR Newswire)that the FTC case ended in dismissal in October 2023 without a ruling on the merits
The Federal Trade Commission (FTC) has dismissed its administrative enforcement action against Axon Enterprise Inc.
read, but no claim rests on it - S12primarycompany filing2026-02-12Motorola Solutions Form 10-K for the fiscal year ended December 31, 2025 Motorola Solutions, Inc.a listed rival's body cameras, evidence software and command centre products, and their weight in its sales
Video: Cameras (fixed, body-worn, in-vehicle), access control, sensors, infrastructure, video management, video monitoring, software and AI-powered analytics
backsC25 - S13primaryregulator2026-07-06DOJ and DHS, Counter-UAS Authority for State, Local, Tribal, and Territorial Law Enforcement: interim final rule (Federal Register, 6 July 2026) US Department of Justice and Department of Homeland Securitythat state and local police may run counter-drone operations from 1 July 2026, under federal training and approved systems
codify the framework for implementing the SAFER SKIES Act, which authorizes State, local, Tribal, and territorial law enforcement or correctional
backsC37 - S14secondaryvendor data2026-11-09Research pack frozen beside this thesis, 2026-11-09content/AXON/research-pack.jsonthe 6 November close, returns and their decomposition, daily closes around results, estimates, the rating split and its history, target drift, valuation history, headcount and FINRA short interestbacksC16C17C20C40C44C45C51
- S15primarycompany filing2026-11-09every open-market insider sale in the year and whether it was under a Rule 10b5-1 planbacksC31
- S16primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC53
- S17secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC52C53